RxDoctor Payments DataLook up a doctor →

Jose David, MD

Family Medicine · Albany, NYNPI 1831181981

Payments from drug & device makers

$105,578in general payments, 2019–2025

Across 1,594 payments — averaging $66.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$37K
  • Johnson & Johnson$29K
  • Idorsia Pharmaceuticals US Inc$11K
  • Renalytix AI, Inc.$3K
  • AstraZeneca$3K
  • Sanofi-aventis U.S. LLC$2K
  • plus $21K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)372$36,542
Johnson & Johnson143$28,799
Idorsia Pharmaceuticals US Inc19$11,112
Renalytix AI, Inc.21$3,107
AstraZeneca61$2,709
Sanofi-aventis U.S. LLC10$2,353
Novo Nordisk122$1,710
Lilly USA, LLC58$1,308
Gilead44$1,051
Amgen36$925
Astellas Pharma US Inc28$897
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC50$831
Pfizer58$784
Bayer33$778
GSK12$745
Axsome Therapeutics, Inc.34$707
Esperion Therapeutics, Inc.32$663
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)23$649
Neurocrine Biosciences, Inc.15$645
Braeburn Inc.28$559
Abbott19$501
Vanda Pharmaceuticals Inc.15$486
Alnylam Pharmaceuticals Inc.13$481
Indivior Inc.27$474
Teva Pharmaceuticals USA, Inc.15$446
Otsuka America Pharmaceutical, Inc.17$420
Orexo US, Inc.17$409
Merck22$382
Alkermes, Inc.12$366
Boehringer Ingelheim10$310
Lundbeck LLC13$274
Novartis15$264
Kowa Pharmaceuticals America, Inc.13$262
Galderma Laboratories, L.p.6$243
Eisai Inc.13$207
Avanir Pharmaceuticals, Inc.5$205
Takeda Pharmaceuticals U.S.A., Inc.10$186
Biohaven Pharmaceuticals, Inc.13$182
IBSA Pharma Inc.10$171
Daiichi Sankyo Inc.12$168
Exact Sciences7$146
Biohaven Pharmaceutical Holding Company Ltd.12$137
Dexcom, Inc.8$134
Paratek Pharmaceuticals, Inc.6$133
Phathom Pharmaceuticals, Inc.2$131
Nestle Healthcare Nutrition Inc.6$116
Urovant Sciences Inc1$102
Endo Pharmaceuticals Inc.6$96
Sumitomo Pharma America, Inc.7$93
Arbor Pharmaceuticals, Inc.5$87
Bausch Health US, LLC4$84
Biogen4$83
Sunovion Pharmaceuticals Inc.5$81
E.r. Squibb & Sons, L.L.C.4$76
Ironwood Pharmaceuticals, Inc3$62
UCB, Inc.2$61
Verona Pharma, Inc.2$54
Seqirus USA Inc3$53
Collegium Pharmaceutical, Inc.3$52
Scilex Pharmaceuticals Inc.3$45

How this compares

$105,578 in reported general payments places this provider in the 95th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York

Medicare billing

Part B allowed, 2024
$202,457
Medicare patients
387
Services billed
2,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →